Literature DB >> 6149266

Nicotinic stimulation of [3H]acetylcholine release from mouse cerebral cortical synaptosomes.

P P Rowell, D L Winkler.   

Abstract

The effects of nicotine and 1,1-dimethyl-4-phenylpiperazinium (DMPP) on the release of newly synthesized [3H]acetylcholine in mouse cerebral cortical synaptosomes were examined. Nicotine and DMPP produced increases in [3H]acetylcholine release, over the level of spontaneous release, of 24% and 30%, respectively, of a maximum depolarization-induced release produced by 50 mM potassium. The maximum effect was achieved at a concentration of 1 X 10(-4) M for both agents. The time course of release indicated a slow onset of action, reaching a maximum effect at 15 min of incubation. Both nicotine and DMPP also produced a slightly greater release of total tritium, measured in the absence of cholinesterase inhibition, than of [3H]acetylcholine. The release induced by nicotine was completely antagonized by hexamethonium and was largely (58%) calcium-dependent. Nicotine also produced an increase in [3H]choline accumulation into synaptosomes. These results indicate that the nicotinic agonists nicotine and DMPP can produce a moderate enhancement of acetylcholine release by a receptor-mediated action on cholinergic nerve terminals in the central nervous system.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6149266     DOI: 10.1111/j.1471-4159.1984.tb06083.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  27 in total

1.  No involvement of nicotinic receptors in the facilitation of acetylcholine outflow in mouse cortex in the presence of neostigmine and atropine.

Authors:  L Iannazzo; H Majewski
Journal:  Br J Pharmacol       Date:  2000-08       Impact factor: 8.739

Review 2.  Immunohistochemistry of cholinergic receptors.

Authors:  H Schröder
Journal:  Anat Embryol (Berl)       Date:  1992-10

3.  Cortical nicotinic receptors in Alzheimer's disease and Parkinson's disease.

Authors:  K W Lange; F R Wells; M N Rossor; P Jenner; C D Marsden
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-04       Impact factor: 10.154

4.  Pharmacological characterization of nicotine-induced acetylcholine release in the rat hippocampus in vivo: evidence for a permissive dopamine synapse.

Authors:  R T Reid; G K Lloyd; T S Rao
Journal:  Br J Pharmacol       Date:  1999-07       Impact factor: 8.739

Review 5.  Desensitization of central cholinergic mechanisms and neuroadaptation to nicotine.

Authors:  E L Ochoa; L Li; M G McNamee
Journal:  Mol Neurobiol       Date:  1990 Fall-Winter       Impact factor: 5.590

Review 6.  The cognitive psychopharmacology of Alzheimer's disease: focus on cholinergic systems.

Authors:  A D Lawrence; B J Sahakian
Journal:  Neurochem Res       Date:  1998-05       Impact factor: 3.996

Review 7.  Nicotinic system involvement in Alzheimer's and Parkinson's diseases. Implications for therapeutics.

Authors:  P A Newhouse; A Potter; E D Levin
Journal:  Drugs Aging       Date:  1997-09       Impact factor: 3.923

Review 8.  Cholinergic markers in Alzheimer disease and the autoregulation of acetylcholine release.

Authors:  R Quirion
Journal:  J Psychiatry Neurosci       Date:  1993-11       Impact factor: 6.186

9.  Nerve terminal currents induced by autoreception of acetylcholine release.

Authors:  W M Fu; H C Liou; Y H Chen
Journal:  J Neurosci       Date:  1998-12-01       Impact factor: 6.167

10.  Presynaptic actions of curare and atropine on quantal acetylcholine release at a central synapse of Aplysia.

Authors:  G Baux; L Tauc
Journal:  J Physiol       Date:  1987-07       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.